Tejay Fletcher, 35, founded and ran a complex banking scam called iSpoof, brought down in 2022 in the UK's biggest fraud sting. The website enabled criminals to appear as if they were calling from ...

A Democratic state representative reportedly clingwrapped a Republican colleague’s BMW on Thursday as a “prank” for him partially parking in her spot. “My good colleague from the 51st ...

The pinnacle of luxury indulgence, yacht travel is a rare amalgamation of adventure and relaxation as you cruise through pristine waters. Often promising spacious cabins and exquisite dining ...

Arsenal centre-back Gabriel Magalhaes is one of three top targets for Saudi Pro League side Al-Nassr this summer, according to reports. The Gunners have had a disappointing season in the Premier ...

alleges in his countersuit that Sun was eager to sell the Giacometti in the wake of the 2022 cryptocurrency crash and the subsequent theft by hackers of $115m from two firms tied to Sun.

Descartes Systems Group announced that it has acquired Columbus, Ohio-based 3GTMS to strengthen its transportation management offerings. The Descartes 3GTMS acquisition was completed for approximately ...

My prospect rankings for the 2025 NFL draft are finally set -- and I expanded the list. Round 1 begins April 24, and we'll see a bunch of talented players fly off the board. Let's stack the top 200.

Logically Answered 115M Downloads, No Business Model - How BeReal Lost Everything Posted: April 17, 2025 | Last updated: April 17, 2025 📉 BeReal skyrocketed to #1 on the App Store with 80M ...

According to The Telegraph, Chelsea star Caicedo is ‘the subject of transfer interest from Al-Nassr’, two years on from his £115m switch from Brighton to Stamford Bridge. The report claims ...

The funding will be used to advance GLM101 into a Phase IIb trial: Credit: Malte Mueller via Getty Images. Glycomine has raised $115m in Series C financing to advance its lead investigational therapy, ...

Glycomine, a biotechnology startup working on a treatment for a rare genetic disorder, has raised a $115 million Series C round to push its lead program deeper into clinical testing. The funding ...